Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology

Journal of Controlled Release

Volumn 159, Issue 1, 2012, Pages 43-51

  Chen, Xinyuan ^a   Shah, Dilip ^a   Kositratna, Garuna ^a   Manstein, Dieter ^a   Anderson, Richard R ^b   Wu, Mei X ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

Drug; Laser; Tape stripping; Transcutaneous delivery; Transdermal patch; Vaccine

Indexed keywords

DATA SUPPORT; DENDRITIC CELLS; DERMAL TISSUES; DRUG; FREE PATH; HYDROPHILIC DRUGS; IMMUNE RESPONSE; IN-CONTROL; LANGERHANS CELLS; LASER TECHNOLOGIES; LATERAL SURFACE; LYMPH NODE; METHYLENE BLUE; OVALBUMINS; SHARP CONTRAST; SKIN DAMAGE; SKIN SURFACES; STRATUM CORNEUM; SULFORHODAMINE B; TAPE STRIPPING; TRANSCUTANEOUS; TRANSCUTANEOUS DELIVERY; TRANSDERMAL; UNTREATED CONTROL; VACCINE DELIVERY;

AROMATIC COMPOUNDS; DRUG DELIVERY; IMMUNOLOGY; LASERS; SKIN; TISSUE;

VACCINES;

METHYLENE BLUE; OVALBUMIN; SULFORHODAMINE B;

ABLATIVE FRACTIONAL LASER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; HYDROPHILICITY; IMMUNE RESPONSE; IMMUNIZATION; LANGERHANS CELL; LASER; LYMPH NODE; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CELL; SKIN PENETRATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIGENS; DRUG DELIVERY SYSTEMS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; IMMUNIZATION; LASER THERAPY; MALE; METHYLENE BLUE; MICE; MICE, INBRED BALB C; OVALBUMIN; RHODAMINES; SKIN; VACCINES;

EID: 84862811547     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.01.002     Document Type: Article

References (36)

1. M.R. Prausnitz, and R. Langer Transdermal drug delivery Nat. Biotechnol. 26 2008 1261 1268
2. G.M. Glenn, and R.T. Kenney Mass vaccination: solutions in the skin Curr. Top. Microbiol. Immunol. 304 2006 247 268
3. H.A. Benson Transdermal drug delivery: penetration enhancement techniques Curr. Drug Deliv. 2 2005 23 33
4. N.B. Smith Perspectives on transdermal ultrasound mediated drug delivery Int. J. Nanomed. 2 2007 585 594
5. N.A. Charoo, Z. Rahman, M.A. Repka, and S.N. Murthy Electroporation: an avenue for transdermal drug delivery Curr. Drug Deliv. 7 2010 125 136
6. N. Dixit, V. Bali, S. Baboota, A. Ahuja, and J. Ali Iontophoresis-an approach for controlled drug delivery: a review Curr. Drug Deliv. 4 2007 1 10
7. A.G. Doukas, and N. Kollias Transdermal drug delivery with a pressure wave Adv. Drug Deliv. Rev. 56 2004 559 579
8. M.R. Prausnitz Microneedles for transdermal drug delivery Adv. Drug Deliv. Rev. 56 2004 581 587
9. G.M. Glenn, C.P. Villar, D.C. Flyer, A.L. Bourgeois, R. McKenzie, R.M. Lavker, and S.A. Frech Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum Infect. Immun. 75 2007 2163 2170
10. Y.W. Noh, T.H. Kim, J.S. Baek, H.H. Park, S.S. Lee, M. Han, S.C. Shin, and C.W. Cho In vitro characterization of the invasiveness of polymer microneedle against skin Int. J. Pharm. 397 2010 201 205
11. J.W. Lee, P. Gadiraju, J.H. Park, M.G. Allen, and M.R. Prausnitz Microsecond thermal ablation of skin for transdermal drug delivery J. Control. Release 154 2011 58 68
12. D.M. Frerichs, L.R. Ellingsworth, S.A. Frech, D.C. Flyer, C.P. Villar, J. Yu, and G.M. Glenn Controlled, single-step, stratum corneum disruption as a pretreatment for immunization via a patch Vaccine 26 2008 2782 2787
13. W.R. Lee, T.L. Pan, P.W. Wang, R.Z. Zhuo, C.M. Huang, and J.Y. Fang Erbium:YAG laser enhances transdermal peptide delivery and skin vaccination J. Control. Release 128 2008 200 208
14. D. Manstein, G.S. Herron, R.K. Sink, H. Tanner, and R.R. Anderson Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury Lasers Surg. Med. 34 2004 426 438
15. M. Haedersdal, F.H. Sakamoto, W.A. Farinelli, A.G. Doukas, J. Tam, and R.R. Anderson Fractional CO(2) laser-assisted drug delivery Lasers Surg. Med. 42 2010 113 122
16. W.R. Lee, S.C. Shen, S.A. Al Suwayeh, H.H. Yang, C.Y. Yuan, and J.Y. Fang Laser-assisted topical drug delivery by using a low-fluence fractional laser: imiquimod and macromolecules J. Control. Release 153 2011 240 248
17. W.R. Lee, S.C. Shen, M.H. Pai, H.H. Yang, C.Y. Yuan, and J.Y. Fang Fractional laser as a tool to enhance the skin permeation of 5-aminolevulinic acid with minimal skin disruption: a comparison with conventional erbium:YAG laser J. Control. Release 145 2010 124 133
18. M. Boes, J. Cerny, R. Massol, d.B. Op, T. Kirchhausen, J. Chen, and H.L. Ploegh T-cell engagement of dendritic cells rapidly rearranges MHC class II transport Nature 418 2002 983 988
19. S. Godefroy, M. Peyre, N. Garcia, S. Muller, D. Sesardic, and C.D. Partidos Effect of skin barrier disruption on immune responses to topically applied cross-reacting material, CRM(197), of diphtheria toxin Infect. Immun. 73 2005 4803 4809
20. J. Inoue, S. Yotsumoto, T. Sakamoto, S. Tsuchiya, and Y. Aramaki Changes in immune responses to antigen applied to tape-stripped skin with CpG-oligodeoxynucleotide in NC/Nga mice Pharm. Res. 22 2005 1627 1633
21. R.T. Kenney, J. Yu, M. Guebre-Xabier, S.A. Frech, A. Lambert, B.A. Heller, L.R. Ellingsworth, J.E. Eyles, E.D. Williamson, and G.M. Glenn Induction of protective immunity against lethal anthrax challenge with a patch J. Infect. Dis. 190 2004 774 782
22. X. Chen, P. Kim, B. Farinelli, A. Doukas, S.H. Yun, J.A. Gelfand, R.R. Anderson, and M.X. Wu A novel laser vaccine adjuvant increases the motility of antigen presenting cells PLoS One 5 2010 e13776
23. A.A. Itano, S.J. McSorley, R.L. Reinhardt, B.D. Ehst, E. Ingulli, A.Y. Rudensky, and M.K. Jenkins Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity Immunity 19 2003 47 57
24. M. Alam, T.S. Hsu, J.S. Dover, D.A. Wrone, and K.A. Arndt Nonablative laser and light treatments: histology and tissue effects-a review Lasers Surg. Med. 33 2003 30 39
25. G.Y. Chen, and G. Nunez Sterile inflammation: sensing and reacting to damage Nat. Rev. Immunol. 10 2010 826 837
26. B. Combadiere, and C. Liard Transcutaneous and Intradermal vaccination Hum. Vaccin. 7 2011
27. S.M. Bal, Z. Ding, E. van Riet, W. Jiskoot, and J.A. Bouwstra Advances in transcutaneous vaccine delivery: do all ways lead to Rome? J. Control. Release 148 2010 266 282
28. J.M. Lofquist, N.A. Weimert, and M.S. Hayney Smallpox: a review of clinical disease and vaccination Am. J. Health Syst. Pharm. 60 2003 749 756
29. R.B. Belshe, F.K. Newman, J. Cannon, C. Duane, J. Treanor, C. Van Hoecke, B.J. Howe, and G. Dubin Serum antibody responses after intradermal vaccination against influenza N. Engl. J. Med. 351 2004 2286 2294
30. R.T. Kenney, S.A. Frech, L.R. Muenz, C.P. Villar, and G.M. Glenn Dose sparing with intradermal injection of influenza vaccine N. Engl. J. Med. 351 2004 2295 2301
31. P. Van Damme, R. Arnou, F. Kafeja, A. Fiquet, P. Richard, S. Thomas, G. Meghlaoui, S.I. Samson, and E. Ledesma Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study BMC Infect. Dis. 10 2010 134
32. J.P. Bryan, M.H. Sjogren, P.L. Perine, and L.J. Legters Low-dose intradermal and intramuscular vaccination against hepatitis B Clin. Infect. Dis. 14 1992 697 707
33. R.R. Redfield, B.L. Innis, R.M. Scott, H.G. Cannon, and W.H. Bancroft Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy JAMA 254 1985 3203 3206
34. M.J. Warrell, D.A. Warrell, P. Suntharasamai, C. Viravan, A. Sinhaseni, D. Udomsakdi, R. Phanfung, C. Xueref, J.C. Vincent-Falquet, K.G. Nicholson, D. Bunnag, and T. Harinasuta An economical regimen of human diploid cell strain anti-rabies vaccine for post-exposure prophylaxis Lancet 2 1983 301 304
35. K.A. Barraclough, K.J. Wiggins, C.M. Hawley, C.L. van Eps, D.W. Mudge, D.W. Johnson, M. Whitby, S. Carpenter, and E.G. Playford Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination Am. J. Kidney Dis. 54 2009 95 103
36. P.H. Lambert, and P.E. Laurent Intradermal vaccine delivery: will new delivery systems transform vaccine administration? Vaccine 26 2008 3197 3208